
TPOXX contains the active ingredient tecovirimat in the form of tecovirimat monohydrate. It acts as an inhibitor of the orthopoxvirus VP37 envelope wrapping protein and is available in two formulations: capsules for oral use and injection for intravenous use. The capsules contain 200 mg of tecovirimat and key inactive ingredients such as colloidal silicon dioxide, croscarmellose sodium, and lactose monohydrate. The injection formulation contains 200 mg of tecovirimat per 20 mL, along with hydroxypropyl betadex and water for injection.